AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34649223 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir (200 mg on the first day followed by 100 mg daily for the next 9 days intravenously infused over 30‐60 minutes) in addition to standard care
Number of subjects: 200
Study 34649223 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 200
Study 34649223 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 200
Study 36396600 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual daily activities for 8 weeks)
Number of subjects: 20
Study 32845388 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram based on US radiomics analysis
Number of subjects: 343
Study 36038172 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 bolus (180,000 IU) maintained by daily dose of 2000 IU
Number of subjects: 0
Study 36038172 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc gluconate (40 mg daily)
Number of subjects: 0
Study 36038172 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36038172 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 and Zinc
Number of subjects: 0
Study 34520841 — intervention group
Group type: EXPERIMENTAL
Intervention: Pars plana vitrectomy (PPV)
Number of subjects: 88
Study 34520841 — intervention group
Group type: COMPARATOR
Intervention: Pneumatic retinopexy (PnR)
Number of subjects: 88
Study 34520841 — intervention group
Group type: EXPERIMENTAL
Intervention: PPV with ORFs
Number of subjects: 88
Study 34520841 — intervention group
Group type: EXPERIMENTAL
Intervention: PPV without ORFs
Number of subjects: 88
Study 34520841 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with ORFs
Number of subjects: 88
Study 34520841 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without ORFs
Number of subjects: 88
Study 34520841 — intervention group
Group type: EXPERIMENTAL
Intervention: PPV
Number of subjects: 88
Study 35217796 — intervention group
Group type: EXPERIMENTAL
Intervention: LSD 100 µg
Number of subjects: 28
Study 35217796 — intervention group
Group type: EXPERIMENTAL
Intervention: LSD 200 µg
Number of subjects: 28
Study 35217796 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin 15 mg
Number of subjects: 28
Study 35217796 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin 30 mg
Number of subjects: 28
Study 35217796 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 35217796 — intervention group
Group type: EXPERIMENTAL
Intervention: LSD (both doses)
Number of subjects: 28
Study 35217796 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin
Number of subjects: 28
Study 35217796 — intervention group
Group type: EXPERIMENTAL
Intervention: LSD
Number of subjects: 28
Study 35217796 — intervention group
Group type: EXPERIMENTAL
Intervention: Both LSD and psilocybin
Number of subjects: 28
Study 35311437 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi (TC)
Number of subjects: 182
Study 35311437 — intervention group
Group type: COMPARATOR
Intervention: Health Education (HAP-E)
Number of subjects: 182
Study 32962906 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse Sugar Tong splint (RST)
Number of subjects: 140
Study 32962906 — intervention group
Group type: COMPARATOR
Intervention: Below Arm Cast (BAC)
Number of subjects: 140
Study 32616248 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytase (2,000 FTU/kg) with 0.12% nonphytate phosphorus (nPP)
Number of subjects: 504
Study 32616248 — intervention group
Group type: COMPARATOR
Intervention: Inorganic phosphate rock supplementation (0.05‐0.30% extra nPP)
Number of subjects: 504
Study 616788766 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy with Jasmine oil
Number of subjects: 120
Study 616788766 — intervention group
Group type: EXPERIMENTAL
Intervention: Aroma therapy with Jasmine oil
Number of subjects: 120
Study 616788766 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine care)
Number of subjects: 120
Study 36109691 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol (1 mg) + Dexamethasone (5 mg)
Number of subjects: 192
Study 36109691 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropisetron (5 mg) + Dexamethasone (5 mg)
Number of subjects: 192
Study 36109691 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone (5 mg) + Saline (5 ml)
Number of subjects: 192
Study 34157193 — intervention group
Group type: EXPERIMENTAL
Intervention: Real group (rTMS at 10 Hz and 100% motor threshold)
Number of subjects: 56
Study 34157193 — intervention group
Group type: COMPARATOR
Intervention: Sham group (control)
Number of subjects: 56
Study 32167305 — intervention group
Group type: EXPERIMENTAL
Intervention: Sanitation intervention (dual-pit latrines, sani-scoops, child potties)
Number of subjects: 0
Study 32167305 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 34157219 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed reality application
Number of subjects: 0
Study 34157219 — intervention group
Group type: COMPARATOR
Intervention: Anatomy drawing screencasts (Control)
Number of subjects: 0
Study 33124961 — intervention group
Group type: EXPERIMENTAL
Intervention: Videos with spatial context shifts
Number of subjects: 0
Study 33124961 — intervention group
Group type: COMPARATOR
Intervention: Videos without spatial context shifts
Number of subjects: 0
Study 32096884 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered acupressure intervention
Number of subjects: 207
Study 34519458 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine
Number of subjects: 32
Study 34519458 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 33069871 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-rebalanced binocular iPad game play 5 hours/week for 4 weeks
Number of subjects: 15
Study 33069871 — intervention group
Group type: COMPARATOR
Intervention: Current treatment only
Number of subjects: 15
Study 35105186 — intervention group
Group type: EXPERIMENTAL
Intervention: LSD (50 μg)
Number of subjects: 24
Study 35105186 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 34014814 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Intervention (EI) using patient navigators and social workers
Number of subjects: 344
Study 34014814 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 344
Study 34014814 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Intervention (EI)
Number of subjects: 344
Study 36245387 — intervention group
Group type: EXPERIMENTAL
Intervention: Boxing training with kicking techniques (BK)
Number of subjects: 29
Study 36245387 — intervention group
Group type: COMPARATOR
Intervention: Boxing alone training (BO)
Number of subjects: 29
Study 34841526 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab 70 mg
Number of subjects: 630
Study 34841526 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab 140 mg
Number of subjects: 630
Study 34841526 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 630
Study 33295851 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin-galactomannan (CGM) 500 mg twice daily for 30 days
Number of subjects: 18
Study 35732486 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement intervention including monthly feedback, interactive education, action toolbox, and bimonthly surveys.
Number of subjects: 32923
Study 35732486 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement intervention
Number of subjects: 32923
Study 35732486 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement intervention with QII
Number of subjects: 32923
Study 35732486 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement intervention without QII
Number of subjects: 32923
Study 35589354 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 300
Study 35589354 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 300
Study 35589354 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 300
Study 33863775 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal hyperglycaemia >8 mmol/L
Number of subjects: 533
Study 33863775 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal hyperglycaemia >8 mmol/L for 3 consecutive days
Number of subjects: 533
Study 33863775 — intervention group
Group type: COMPARATOR
Intervention: Insulin treatment
Number of subjects: 533
Study 32081851 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age of menarche
Number of subjects: 8327
Study 32081851 — intervention group
Group type: EXPERIMENTAL
Intervention: Later age at menarche
Number of subjects: 8327
Study 34586459 — intervention group
Group type: EXPERIMENTAL
Intervention: Levilimab (LVL) 324 mg
Number of subjects: 217
Study 34586459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217
Study 32066497 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g/8 h by continuous infusion (CI)
Number of subjects: 31
Study 32066497 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g/8 h by continuous infusion (CI)
Number of subjects: 31
Study 32066497 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g/day (theoretical highest dose)
Number of subjects: 31
Study 35699610 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced navigation partnered with legal advocates
Number of subjects: 220
Study 35699610 — intervention group
Group type: COMPARATOR
Intervention: Standard patient navigation
Number of subjects: 220
Study 32488654 — intervention group
Group type: EXPERIMENTAL
Intervention: Endobiliary radiofrequency ablation (EB-RFA) with a temperature-controlled catheter (ELRA™) followed by self-expanding metal stent (SEMS) placement
Number of subjects: 48
Study 32488654 — intervention group
Group type: COMPARATOR
Intervention: Self-expanding metal stent (SEMS) placement only (non-RFA group)
Number of subjects: 48
Study 36168108 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance Care Planning (ACP) conversations
Number of subjects: 37
Study 35226640 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety-net antibiotic prescription (SNAP) offered to patients with AOM.
Number of subjects: 8226
Study 32046764 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 30
Study 32046764 — intervention group
Group type: COMPARATOR
Intervention: Non-invasive sham control
Number of subjects: 30
Study 36122763 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-loss diets with different macronutrient intakes
Number of subjects: 515
Study 34987316 — intervention group
Group type: EXPERIMENTAL
Intervention: Directional Coronary Atherectomy (DCA) followed by drug-coated balloon (DCB) angioplasty
Number of subjects: 31
Study 34987316 — intervention group
Group type: EXPERIMENTAL
Intervention: Directional Coronary Atherectomy (DCA)
Number of subjects: 31
Study 32804580 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutrophil-to-lymphocyte ratio (NLR) and C-reactive protein (CRP) combined detection
Number of subjects: 191
Study 32804580 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate group of COVID-19 patients
Number of subjects: 191
Study 32804580 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 191
Study 32804580 — intervention group
Group type: EXPERIMENTAL
Intervention: NLR, CRP, and lymphocyte percentage
Number of subjects: 191
Study 32804580 — intervention group
Group type: EXPERIMENTAL
Intervention: NLR, CRP, WBC, and lymphocyte percentage
Number of subjects: 191
Study 33729249 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised 'spot-scan' mode of imaging in STEM
Number of subjects: 0
Study 33729249 — intervention group
Group type: COMPARATOR
Intervention: Uniformly illuminated TEM mode of imaging
Number of subjects: 0
Study 33380614 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection
Number of subjects: 24
Study 33380614 — intervention group
Group type: COMPARATOR
Intervention: Saline injection (Control)
Number of subjects: 24
Study 32592596 — intervention group
Group type: EXPERIMENTAL
Intervention: COC + VPR (2 mg/d vilaprisan)
Number of subjects: 71
Study 32592596 — intervention group
Group type: COMPARATOR
Intervention: COC + Placebo
Number of subjects: 71
Study 33039321 — intervention group
Group type: EXPERIMENTAL
Intervention: Fertility education chatbot
Number of subjects: 927
Study 33039321 — intervention group
Group type: COMPARATOR
Intervention: Document about fertility and preconception health (Control group 1)
Number of subjects: 927
Study 33039321 — intervention group
Group type: COMPARATOR
Intervention: Document about an irrelevant topic (Control group 2)
Number of subjects: 927
Study 32970283 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically longer self-reported sleep duration
Number of subjects: 0
Study 32970283 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer self-reported sleep duration
Number of subjects: 0
Study 32970283 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerometer-derived sleep duration
Number of subjects: 0
Study 32970283 — intervention group
Group type: COMPARATOR
Intervention: Self-reported sleep duration
Number of subjects: 0
Study 36442186 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid warm-up intervention (HWU)
Number of subjects: 120
Study 36442186 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic warm-up intervention (DWU)
Number of subjects: 120
Study 36442186 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching warm-up intervention (SWU)
Number of subjects: 120
Study 36442186 — intervention group
Group type: COMPARATOR
Intervention: No warm-up intervention (NWU)
Number of subjects: 120
Study 35995936 — intervention group
Group type: COMPARATOR
Intervention: Control group (reminder to attend regular screening)
Number of subjects: 6000
Study 35995936 — intervention group
Group type: EXPERIMENTAL
Intervention: Opt-in group (offer to order a self-sampling kit for HPV testing)
Number of subjects: 6000
Study 35995936 — intervention group
Group type: EXPERIMENTAL
Intervention: Send-to-all group (self-sampling kit unsolicited for HPV testing)
Number of subjects: 6000
Study 35995936 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-sampling (both opt-in and send-to-all)
Number of subjects: 6000
Study 35995936 — intervention group
Group type: COMPARATOR
Intervention: Clinician-collected samples
Number of subjects: 6000
Study 33840798 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat oral immunotherapy (WOIT)
Number of subjects: 0
Study 35377238 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-directed music (PDM) listening protocol
Number of subjects: 126
Study 34350266 — intervention group
Group type: EXPERIMENTAL
Intervention: Total left‐sided surgical approach (TLSA)
Number of subjects: 114
Study 34350266 — intervention group
Group type: COMPARATOR
Intervention: Traditional bilateral surgical approach (TBSA)
Number of subjects: 114
Study 36430967 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 1 mg/day for 1 year
Number of subjects: 23
Study 36430967 — intervention group
Group type: COMPARATOR
Intervention: Hypertensive controls
Number of subjects: 23
Study 34383515 — intervention group
Group type: EXPERIMENTAL
Intervention: Moms' Empowerment Program
Number of subjects: 118
Study 34383515 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 118
Study 34383515 — intervention group
Group type: COMPARATOR
Intervention: Higher IPV exposure
Number of subjects: 118
Study 34383515 — intervention group
Group type: COMPARATOR
Intervention: Higher depression symptoms
Number of subjects: 118
Study 34383515 — intervention group
Group type: COMPARATOR
Intervention: Shelter use
Number of subjects: 118
Study 32886189 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month exercise program (weekly supervised step aerobics, circuit exercises, and home training)
Number of subjects: 573
Study 32886189 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 573
Study 32886189 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month exercise program
Number of subjects: 573
Study 32886189 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 573
Study 33030312 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate (DMPA)
Number of subjects: 0
Study 33030312 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in DMPA use among HIV-positive women
Number of subjects: 0
Study 33030312 — intervention group
Group type: EXPERIMENTAL
Intervention: Switching away from DMPA to no contraceptive method
Number of subjects: 0
Study 36201131 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-off screening at age 50 years
Number of subjects: 10000000
Study 36201131 — intervention group
Group type: COMPARATOR
Intervention: All screening strategies
Number of subjects: 10000000
Study 36201131 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygenic risk-stratified screening strategies
Number of subjects: 10000000
Study 36201131 — intervention group
Group type: COMPARATOR
Intervention: No screening
Number of subjects: 10000000
Study 32938990 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled prostaglandin-E2 (PGE2) 100 μg
Number of subjects: 17
Study 32938990 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled bradykinin (BK) 200 μg
Number of subjects: 17
Study 32938990 — intervention group
Group type: COMPARATOR
Intervention: Diluent (Control)
Number of subjects: 17
Study 36074603 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentoring group
Number of subjects: 0
Study 36074603 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU) group
Number of subjects: 0
Study 32513182 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg∙kg‐1)
Number of subjects: 20
Study 34896350 — intervention group
Group type: EXPERIMENTAL
Intervention: CSFL risk prediction nomogram
Number of subjects: 1286
Study 32174345 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% body mass (BM) bilateral load
Number of subjects: 24
Study 32174345 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% BM unilateral load
Number of subjects: 24
Study 32174345 — intervention group
Group type: COMPARATOR
Intervention: No load
Number of subjects: 24
Study 36563900 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous (IV) ferric carboxymaltose
Number of subjects: 64
Study 36563900 — intervention group
Group type: COMPARATOR
Intervention: Oral ferrous fumarate
Number of subjects: 64
Study 36563900 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 64
Study 33187676 — intervention group
Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM) model based on radiomics features
Number of subjects: 136
Study 33187676 — intervention group
Group type: COMPARATOR
Intervention: Radiologists
Number of subjects: 136
Study 33367545 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemtuzumab ozogamicin (GO)
Number of subjects: 469
Study 33367545 — intervention group
Group type: COMPARATOR
Intervention: Control group (intensive chemotherapy without GO)
Number of subjects: 469
Study 35501468 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia (SA)
Number of subjects: 95
Study 35501468 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-Guided Caudal Epidural Blocks (CEB)
Number of subjects: 95
Study 34193177 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential finger task in REs
Number of subjects: 27
Study 34193177 — intervention group
Group type: COMPARATOR
Intervention: Sequential reaching task in VEs
Number of subjects: 27
Study 35700246 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise training after inpatient rehabilitation
Number of subjects: 100
Study 35700246 — intervention group
Group type: COMPARATOR
Intervention: Inpatient rehabilitation exercise training
Number of subjects: 100
Study 34257678 — intervention group
Group type: EXPERIMENTAL
Intervention: Ayurveda drug regimen arm II
Number of subjects: 120
Study 34257678 — intervention group
Group type: EXPERIMENTAL
Intervention: Ayurveda drug regimen arm I
Number of subjects: 120
Study 34257678 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 34257678 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 120
Study 34257678 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention arms
Number of subjects: 120
Study 34257678 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental arms
Number of subjects: 120
Study 34257678 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 120
Study 34759244 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 364
Study 34759244 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 364
Study 34759244 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (subgroup for tumors ≤5 cm)
Number of subjects: 364
Study 34759244 — intervention group
Group type: COMPARATOR
Intervention: Open surgery (subgroup for tumors ≤5 cm)
Number of subjects: 364
Study 35688677 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (5 mg/kg) and 0.25% bupivacaine (1 mg/kg)
Number of subjects: 75
Study 35688677 — intervention group
Group type: COMPARATOR
Intervention: 0.25% bupivacaine (1 mg/kg)
Number of subjects: 75
Study 35688677 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (NaCl)
Number of subjects: 75
Study 33244709 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact (SSC) combined with maternal singing during music therapy (MT)
Number of subjects: 35
Study 33244709 — intervention group
Group type: COMPARATOR
Intervention: Skin-to-skin contact (SSC) alone
Number of subjects: 35
Study 37315900 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily probiotic
Number of subjects: 24
Study 37315900 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 37315900 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent fasting
Number of subjects: 24
Study 34297997 — intervention group
Group type: COMPARATOR
Intervention: PICC
Number of subjects: 1061
Study 34297997 — intervention group
Group type: EXPERIMENTAL
Intervention: Hickman
Number of subjects: 1061
Study 34297997 — intervention group
Group type: EXPERIMENTAL
Intervention: PORT
Number of subjects: 1061
Study 35192201 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling
Number of subjects: 101
Study 35192201 — intervention group
Group type: EXPERIMENTAL
Intervention: Rowing
Number of subjects: 101